SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
AmperCap Acquisition Company announced holders can elect to separately trade ordinary shares and rights as of June 29. The listing structure will split the asset into the symbols A…
Worksport regained compliance with Nasdaq's $1 minimum bid price requirement and scheduled an upcoming investor town hall to discuss strategic growth and operational expansion.
The Grayscale Solana Staking ETF amended its Declaration of Trust to adjust the Sponsor Fee. The new terms stipulate a 0.19% annual fee rate payable daily in SOL.
Incannex Healthcare Inc. announced the USPTO has granted a patent covering its proprietary oral therapy IHL-42X for obstructive sleep apnea. This intellectual property milestone st…
The Federal Reserve Board's annual stress test confirms that large banks possess the capital resilience to withstand a severe recession. These institutions remain fully capable of …
Cayman Water received a license from the Utility Regulation and Competition Office to produce and distribute potable water from seawater. This approval facilitates the subsidiary's…
Filing metadata lists Exhibit 10.1 and pages 1 through 10. The visible text contains no substantive financial details or event information.
C4 Therapeutics approved amendment No. 2 to its 2020 plan, authorizing annual share increases of up to 5%. This corporate governance update aims to provide long-term flexibility fo…
Serina Therapeutics filed an amendment to its certificate of incorporation increasing authorized common shares to 125 million and preferred shares to 5 million. This increase provi…
JPMorgan Chase released hypothetical 2026 Dodd-Frank Act Stress Test results for a nine-quarter period under a restrictive economic scenario. The company noted the results reflect …
PIMCO Fund amended its prospectus to allow subprime and foreign loan investments, marking a significant strategic change.
The fund has amended its prospectus to permit direct lending and investment in subprime or unrated debt instruments, expanding its risk profile. This strategic shift increases pote…
PIMCO High Income Fund amended its prospectus to allow investments in subprime loans and increase common stock limits to 20%. These modifications expand the fund's risk tolerance a…
Ionis Pharmaceuticals announced the FDA approval of olezarsen (Tryngolza), a new treatment for severe hypertriglyceridemia. This marks the company's first independent commercial la…
The registrant filed a Current Report on Form 8-K dated June 24, 2026. The text was truncated immediately upon the report of Item 8.01 Other Events, preventing identification of th…
Nasdaq upheld the denial of Aditxt's listing request, suspending trading June 25. The move threatens the company's market access ahead of a shareholder vote to finalize a SPAC merg…
Femasys Inc. announced it received formal notice from Nasdaq confirming compliance with the bid price rule. This resolves a listing compliance issue and allows the company to maint…
Cognition Therapeutics received FDA feedback agreeing that DLB psychosis is an approvable outcome and aligning on its Phase 3 trial design. This regulatory milestone paves the way …
The U.S. DOE has conditionally committed $17.5 billion in loans to support ten Westinghouse nuclear reactors, leveraging Brookfield's majority ownership. This funding aims to accel…
Teucrium Commodity Trust filed a Form 8-K referencing a letter from Grant Thornton LLP. The filing confirms the senior accountant's agreement with recent disclosure statements.